Medical Science Building (MSB) 185 South Orange Avenue Room E534 Newark, NJ 07101 Phone: (973) 972-5055
Additional Links:
Hospital Affiliation
University Hospital, Newark Jersey City Medical Center
Insurance Participation
Insurance Participation: with Provider Number (where applicable) The information below is subject to change and should not be relied upon until after
it is verified with the insurance company. In addition, psychiatric providers should
be contacted directly for information on their participation with managed care and
insurance companies.
Dr. Ana Tergas is the Director of Gynecologic Oncology at Rutgers New Jersey Medical School and
University Hospital. A 2024 Rutgers Presidential Faculty Scholar and member of the Rutgers Hispanic
Center of Excellence, she is an NIH-funded physician-scientist whose work focuses on health
inequities in gynecologic cancer outcomes, end-of-life care, and HPV and cervical cancer prevention.
She has been recognized by the NIH and the National Cancer Institute for her leadership in health
disparities research and previously served on an NCI career development grant review study section.
Dr. Tergas trained at the University of Miami, the University of Chicago, and Johns Hopkins University,
where she also earned her MPH. She previously served on the faculty at Columbia University and
completed an NIH R25 postdoctoral fellowship in Cancer-Related Population Sciences at the
Mailman School of Public Health. Prior to joining Rutgers, she served on the faculty at City of Hope
Comprehensive Cancer Center, where she held joint appointments in the Department of Surgery,
Gynecologic Oncology Division, and the Department of Population Sciences, Health Equity Division.
She is active in national gynecologic oncology organizations, has held multiple leadership roles within
the Society of Gynecologic Oncology, and serves on the editorial boards of Gynecologic
Oncology and the Journal of Surgical Oncology. A committed mentor, Dr. Tergas supports trainees at
all levels and has contributed to several national diversity and health equity initiatives.
Education and Training:
College
University of Florida, Gainesville, FL, Bachelor of Science, 2000
Graduate School
John Hopkins Bloomberg School of Public Health, Baltimore, MD, Master of Public Health, 2011
Medical School
University of Miami Miller School of Medicine, FL, Medical Doctor, 2006
POST GRADUATE EDUCATION AND TRAINING
Residency
University of Chicago Hospitals, Chicago, IL, Obstetrics and Gynecology, July 2006 - June 2010
Fellowship
Johns Hopkins Medical Institutions, Baltimore, MD, Gynecologic Oncology, July 2010 - June 2013
Post-graduate
Columbia University Mailman School of Public Health, New York, NY, Post-doctoral research scientist,
July 2013 - July 2015
Education
MD, 2011, Johns Hopkins Bloomberg School of Public Health
Licensure & Certification
Medical Licensure New Jersey
Relevant Publications
1. Tergas AI, Prigerson HG, Penedo FJ, Maciejewski PK. Human Connection: Oncologist
Characteristics and Behaviors Associated With Therapeutic Bonding With Latino Patients With
Advanced Cancer. JCO Oncol Pract. 2024 Jan;20(1):111-122. doi: 10.1200/OP.23.00329. Epub 2023
Nov 21. PMID: 37988650
2. Tergas AI, Prigerson HG, Shen MJ, Neugut AI, Maciejewski PK. Disparities in Therapeutic Alliance
Among Latino Immigrants With Advanced Cancer. J Pain Symptom Manage. 2022 Sep;64(3):e173-
e176. doi: 10.1016/j.jpainsymman.2022.06.003. Epub 2022 Jun 11. PMID: 35700931
3. Tergas AI, Prigerson HG, Shen MJ, Dinicu AI, Neugut AI, Wright JD, Hershman DL, Maciejewski PK.
Association between immigrant status and advanced cancer patients' location and quality of death.
Cancer. 2022 Sep 15;128(18):3352-3359. doi: 10.1002/cncr.34385. Epub 2022 Jul 8. PMID: 35801713
5. Tergas AI, Einstein MH.The Future of Cervical Cancer Screening Is Now. Obstet Gynecol. 2025
Jul;146(1):3-5. doi: 10.1097/AOG.0000000000005960. PMID: 40924405
6. Dinicu AI, Dioun S, Wang Y, Huang Y, Wright JD, Tergas AI.??Survival rates in Hispanic/Latinx
subpopulations with cervical cancer associated with disparities in guideline-concordant care. Gynecol
Oncol. 2024 May;184:214-223. doi: 10.1016/j.ygyno.2024.01.043. Epub 2024 Feb 9. PMID: 38340647
7. Cham S, Li A, Rauh-Hain JA, Tergas AI, Hershman DL, Wright JD, Melamed A.??Association
Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York
City. JAMA Oncol. 2022 Jan 1;8(1):159-161. doi: 10.1001/jamaoncol.2021.5779. PMID: 34817550
